AIM BIOTECH Trademark

Trademark Overview


On Thursday, August 22, 2019, a trademark application was filed for AIM BIOTECH with the United States Patent and Trademark Office. The USPTO has given the AIM BIOTECH trademark a serial number of 88588339. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 5, 2023. This trademark is owned by HEMISPHERX BIOPHARMA, INC.. The AIM BIOTECH trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal accidents or burns; Interferons; Parenterally administered interferon for use in treating viral diseases, immunological disorders and cancer; Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS; intranasal solutions for use as a vaccine adjuvant

Pharmaceutical research and development; Pharmaceutical research and development of drugs for the treatment of cancers, viral diseases, immunological disorders and ME/CFS
aim biotech

General Information


Serial Number88588339
Word MarkAIM BIOTECH
Filing DateThursday, August 22, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 5, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 10, 2020

Trademark Statements


Goods and ServicesIntravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal accidents or burns; Interferons; Parenterally administered interferon for use in treating viral diseases, immunological disorders and cancer; Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS; intranasal solutions for use as a vaccine adjuvant
Pseudo MarkAIM BIO TECH
Disclaimer with Predetermined Text"BIOTECH"
Goods and ServicesPharmaceutical research and development; Pharmaceutical research and development of drugs for the treatment of cancers, viral diseases, immunological disorders and ME/CFS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 6, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 6, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAIM IMMUNOTECH INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOCALA, FL 34473

Party NameAIM IMMUNOTECH INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressOCALA, FL 34473

Party NameHEMISPHERX BIOPHARMA, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOrlando, FL 32801

Trademark Events


Event DateEvent Description
Monday, June 5, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 5, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, November 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 2, 2022SOU EXTENSION 5 GRANTED
Tuesday, October 25, 2022SOU EXTENSION 5 FILED
Wednesday, November 2, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 25, 2022TEAS EXTENSION RECEIVED
Friday, May 6, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 4, 2022SOU EXTENSION 4 GRANTED
Wednesday, May 4, 2022SOU EXTENSION 4 FILED
Wednesday, May 4, 2022TEAS EXTENSION RECEIVED
Saturday, November 6, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 4, 2021SOU EXTENSION 3 GRANTED
Thursday, November 4, 2021SOU EXTENSION 3 FILED
Thursday, November 4, 2021TEAS EXTENSION RECEIVED
Friday, May 7, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 5, 2021SOU EXTENSION 2 GRANTED
Wednesday, May 5, 2021SOU EXTENSION 2 FILED
Wednesday, May 5, 2021TEAS EXTENSION RECEIVED
Saturday, November 7, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 5, 2020SOU EXTENSION 1 GRANTED
Thursday, November 5, 2020SOU EXTENSION 1 FILED
Thursday, November 5, 2020TEAS EXTENSION RECEIVED
Thursday, July 23, 2020ASSIGNED TO EXAMINER
Tuesday, May 5, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 10, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 10, 2020PUBLISHED FOR OPPOSITION
Wednesday, February 19, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 31, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, January 4, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 3, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 3, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 25, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 25, 2019NON-FINAL ACTION E-MAILED
Monday, November 25, 2019NON-FINAL ACTION WRITTEN
Friday, November 22, 2019ASSIGNED TO EXAMINER
Wednesday, October 9, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, September 6, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 26, 2019NEW APPLICATION ENTERED